
Why Is Philippe Laffont Buying TSM?
With a personal net worth of approximately $6.5 billion and…
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
Income Statement | ||||||
Revenue | $3B | $1.8B | $2.1B | $306M | $331M | |
Gross Profit | $7.7M | $198.5M | $334.9M | $70.2M | $81.2M | |
Operating Income | -$451.1M | -$241.7M | -$72.4M | -$32.3M | -$9.3M | |
EBITDA | -$438M | -$223.5M | -$93.5M | -$33.1M | -$8.4M | |
Diluted EPS | -$0.94 | -$0.49 | -$0.20 | -$0.09 | -$0.02 |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Balance Sheet | ||||||
Current Assets | -- | $559.3M | $1.5B | $915.7M | $432.7M | |
Total Assets | -- | $952.5M | $1.6B | $1.1B | $653M | |
Current Liabilities | -- | $230.2M | $1.1B | $718.7M | $279.6M | |
Total Liabilities | -- | $540.2M | $1.2B | $737.9M | $310.8M | |
Total Equity | -- | $412.3M | $392M | $321.9M | $342.2M | |
Total Debt | -- | $19.9M | $20M | -- | -- |
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
Cash Flow Statement | ||||||
Cash Flow Operations | -$74.7M | -$178.4M | -$108.6M | -$18.8M | $50M | |
Cash From Investing | -$24M | $69M | $85.7M | -$20.3M | -$12.1M | |
Cash From Financing | $279.4M | $78.2M | -$40.8M | -$2M | -$4.7M | |
Free Cash Flow | -$75.6M | -$183.1M | -$109.6M | -$19M | $49.6M |
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. Operating in two segments, Insurance and Non-Insurance, Clover Health offers PPO and HMO plans to Medicare Advantage members in multiple states through its Insurance segment. In the Non-Insurance segment, the company participates in the ACO REACH Model. The majority of revenue is generated from the insurance segment, reflecting the significance of its healthcare insurance offerings.
In the current month, CLOV has received 2 Buy ratings 2 Hold ratings, and 0 Sell ratings. The CLOV average analyst price target in the past 3 months is $4.80.
According to analysts, the consensus estimate is that Clover Health Investments share price will rise to $4.80 per share over the next 12 months.
Analysts are divided on their view about Clover Health Investments share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Clover Health Investments is a Sell and believe this share price will drop from its current level to $4.20.
The price target for Clover Health Investments over the next 1-year time period is forecast to be $4.80 according to 4 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Clover Health Investments is a Leans Bullish. 2 of 4 analysts rate the stock a Leans Bullish at this time.
You can purchase shares of Clover Health Investments via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Clover Health Investments shares.
Clover Health Investments was last trading at $4.34 per share. This represents the most recent stock quote for Clover Health Investments. Yesterday, Clover Health Investments closed at $4.40 per share.
In order to purchase Clover Health Investments stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
With a personal net worth of approximately $6.5 billion and…
The degree to which the healthcare paradigm has changed is…
While the world focuses on AI, the leaders over at…
Market Cap: $3.7T
P/E Ratio: 40x
Market Cap: $3.3T
P/E Ratio: 113x
Market Cap: $3T
P/E Ratio: 35x
Globant SA [GLOB] is up 2.83% over the past day.
Hims & Hers Health [HIMS] is down 19.28% over the past day.
Vicor [VICR] is down 5.16% over the past day.